Lütfullah Zahit Koç

Lütfullah Zahit Koç


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2026 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
LKLütfullah Zahit Koç
Lütfullah Zahit Koç
SKSevgi Gulsen Koc
Sevgi Gulsen Koc
AIAyca Inci
Ayca Inci
OBOsman Cagin Buldukoglu
Osman Cagin Buldukoglu
GKGokhan Koker
Gokhan Koker
Edgar LermaEdgar Lerma
Edgar Lerma
This study aimed to evaluate the accuracy, content quality, and readability of patient education responses related to chronic kidney disease (CKD) generated by large language models (ChatGPT-4o mini and Gemini) compared to guideline group. Fifteen frequently asked CKD-related questions were selected using global Google Trends data and posed to both AI models and guideline-based sources. Responses were anonymized and evaluated by four independent nephrology professors using the CLEAR Tool, assessing completeness, appropriateness, evidence basis, and clarity. Both AI models significantly outperformed guideline responses across all CLEAR Tool domains (p < 0.001), with ChatGPT-4o mini achieving the highest median score (21.0 [IQR: 5.0] vs. Gemini: 17.0 [IQR: 5.0], Guideline: 13.0 [IQR: 2.0]). Initial readability analysis showed that guideline responses were easier to comprehend (Flesch-Kincaid Grade Level (FKGL): 9.40; Flesch Reading Ease (FRE): 52.01) than AI-generated content (ChatGPT FKGL: 11.34, FRE: 36.17; Gemini FKGL: 9.62, FRE: 46.36). However, when a structured prompt was applied, AI responses demonstrated significant improvements in readability, reducing the required literacy level to approximately the 7th-grade (ChatGPT FKGL: 7.87, FRE: 64.23; Gemini FKGL: 7.13, FRE: 61.45). These findings highlight the potential of prompt-guided AI models to generate accurate, accessible educational content for CKD. Prompt engineering emerges as a practical tool to enhance clarity and usability, particularly for populations with limited health literacy. Integration with frameworks like Retrieval-Augmented Generation may further improve reliability and safety in digital health communication.

23 July 2025 in Turkish Journal of Hematology
Verified
Journal Article
Open access
SKSema Karakuş
Sema Karakuş
ŞBŞule Mine Bakanay
Şule Mine Bakanay
SBSevgi Kalayoglu Besısık
Sevgi Kalayoglu Besısık
AEAhmet Emre Eskazan
Ahmet Emre Eskazan
MAMEHMET ORHAN AYYILDIZ
MEHMET ORHAN AYYILDIZ
MAMuhlis Cem Ar
Muhlis Cem Ar
This study aimed to investigate the clinical manifestations, treatment patterns and clinical outcomes in patients with iTTP across Türkiye via an interim analysis of the Turkish iTTP registry. A total of 215 patients with iTTP (median age at diagnosis 41 years, 58.6% female) diagnosed between 2001 and 2023 were retrospectively analyzed in the interim analysis of the prospective noninterventional observational multicenter iTTP registry study conducted at 19 tertiary hematology centers. Data on patient demographics, disease characteristics on initial admission, treatment characteristics, and responses, exacerbations/relapses, and the survival outcome were registered via electronic case report forms. Infection (15.0%), new drug initiation (9.7%), and pregnancy/postpartum (6.3%) within 3 weeks before diagnosis were the most prevalent potential triggers. Patients presented more commonly with systemic/constitutional (fatigue 68.8%; fever 18.1%) and neurologic (headache 40.0%, vertigo 32.1%), followed by hemorrhagic, gastrointestinal, renal, and cardiovascular manifestations. Based on the PLASMIC risk scoring, 77.8% of patients were initially at high risk for TTP. The initial treatment was commenced within the first 48 hours of hospital admission in 64.1% of patients (36.2% on the day of admission). Treatment was mainly based on TPE exchange (92.1%) and steroids (63.7%), while rituximab was used in 15.8% of patients. The clinical response rate was 79.9%, and clinical remission was achieved in 68.2% of patients. As for the ADAMTS13 levels, partial and complete responses were achieved in 17.7% and 14.6%, respectively. During a median of 30 months (range, 0.1 to 262.4 months) follow-up, 35 patients experienced exacerbations/relapses. Mortality occurred in 11 (5.5%) patients and was found to be disease-related in 6 (3.0%). This interim analysis of the nationwide Turkish iTTP registry study provided valuable data on the real-world clinical practice in the diagnosis and management of iTTP at different hematology clinics across the country.

6 February 2026 in Medicine
Verified
Journal Article
Open access
GKGokhan Koker
Gokhan Koker
KÇKübra Çerçi
Kübra Çerçi
MCMuhammed Ali Coşkuner
Muhammed Ali Coşkuner
LKLütfullah Zahit Koç
Lütfullah Zahit Koç
HEHamit Yaşar Ellidağ
Hamit Yaşar Ellidağ
BBBilgin Bahadır Başgöz
Bilgin Bahadır Başgöz
This study investigates alterations in vaspin levels in hypothyroid patients and their role in metabolic processes and thyroid function. By analyzing the correlation between vaspin levels and hypothyroidism, the research aims to elucidate metabolic dysregulation in thyroid disorders and the potential link between thyroid hormones and adipose tissue function. This study included patients with hypothyroidism and healthy controls. Comprehensive data and laboratory findings were collected from hospital electronic health records. Vaspin levels were analyzed to explore the association with hypothyroidism. The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) was also calculated. The study included 90 participants: 54 in the hypothyroid group and 36 in the control group. The hypothyroid group had a significantly higher age (49.04 ± 11.89 vs 43.53 ± 9.76 years, P = .019). Thyroid function tests showed substantially higher thyroid-stimulating hormone and lower fT4 levels in the hypothyroid group, confirming impaired thyroid function. Notably, vaspin levels were significantly lower in the hypothyroid group than in the control group (2.24 ng/mL vs 3.51 ng/mL, P = .008). This finding suggests that hypothyroidism may lead to altered adipokine regulation, potentially contributing to metabolic dysfunction. No significant differences were observed between the groups for lipid profile, glucose metabolism, insulin resistance (HOMA-IR), hematological, or liver enzymes. This study found lower vaspin levels in hypothyroid patients, which may be related to metabolic dysregulation. Vaspin could serve as a therapeutic target for addressing metabolic disturbances in hypothyroidism. Further research is needed to explore its clinical implications.

Verified
Journal Article
Open access
PDF file
MKmehmet kök
mehmet kök
SDSüleyman DOLU
Süleyman DOLU
Mehmet Emin ArayiciMehmet Emin Arayici
Mehmet Emin Arayici
GKGökhan Köker
Gökhan Köker
LKLütfullah Zahit Koç
Lütfullah Zahit Koç
ACAyhan Hilmi Cekin
Ayhan Hilmi Cekin
Background: Hypolipidemia has been shown to be a factor that elevates the risk of bleeding. This study aimed to investigate the relationship between cholesterol levels and the risk of peptic ulcer bleeding (PUB). Methods: A total of 15,547 patients who underwent esophagogastroduodenoscopy (EGD) between May 2017 and December 2020 were screened. Of these, 317 were included in this retrospective cohort study. PUB was diagnosed by EGD. Serum cholesterol levels were measured at six-month intervals, and cumulative mean cholesterol concentrations were calculated using all available data during the observation period. Results: Ulcer bleeding was detected in 173 (45.6%) patients with peptic ulcer. Patients with bleeding peptic ulcer exhibited significantly lower TC, LDL-C, and HDL-C levels compared to non-bleeding peptic ulcer patients and controls (p < 0.001). The optimal LDL cut-off was 91.50 (p < 0.001), with 75.1% sensitivity and 24.1% specificity. For HDL, the cut-off was 42.50 (p < 0.001), yielding 72.3% sensitivity and 30.1% specificity. A one-unit increase in LDL and HDL reduced the risk of PUB by 0.95-fold and 0.97-fold, respectively. Conclusions: Our findings suggest that reduced cholesterol levels, particularly LDL-C and HDL-C, may elevate the risk of PUB. Therefore, monitoring cholesterol levels in peptic ulcer patients, especially those at higher bleeding risk, could be beneficial.

3 April 2025 in European Journal of Rheumatology
Verified
Journal Article
Open access
GKGokhan Koker
Gokhan Koker
LKLütfullah Zahit Koç
Lütfullah Zahit Koç
SGSevgi Gulsen
Sevgi Gulsen
SBSibel Bakirci
Sibel Bakirci
CACengiz Aldemir
Cengiz Aldemir
Sarcoidosis,tenosynovitis,nodular sarcoidosis,isolated sarcoidosis

10 October 2026 in Medicina
Verified
Journal Article
Open access
PDF file
AAAyşe Karaduru Avcı
Ayşe Karaduru Avcı
AIAyca Inci
Ayca Inci
RARauf Avcı
Rauf Avcı
UBUĞUR BÜYÜKOKUDAN
UĞUR BÜYÜKOKUDAN
FSFatih Sargin
Fatih Sargin
ÜYÜstün Yılmaz
Üstün Yılmaz
Background and Objectives: Long-term renal and cardiovascular outcomes represent major clinical burdens in predialysis chronic kidney disease (CKD). This study aimed to evaluate the long-term incidence of and clinical factors associated with major adverse kidney events (MAKEs) and incident major adverse cardiovascular events (MACEs) in patients with predialysis CKD. Materials and Methods: This retrospective cohort included 263 adults with predialysis CKD followed for at least five years. Patients with baseline dialysis, kidney transplantation, coronary artery disease, heart failure, stroke, or malignancy were excluded. MAKE was defined as chronic dialysis, kidney transplantation, or a ≥50% decline in baseline eGFR. MACE comprised nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. Separate multivariable Cox regression models were constructed for MAKE and MACE, with treatment exposures modeled as time-dependent covariates. Fine–Gray competing-risk regression was performed as a sensitivity analysis. Results: During a median follow-up of 2829 days, MAKE occurred in 97 patients (36.9%) and MACE in 53 (20.2%), corresponding to incidence rates of 47.8 and 26.0 per 1000 person-years, respectively. In multivariable Cox models for MAKE, lower baseline eGFR (HR per 10 mL/min/1.73 m2 increase 0.84, 95% CI 0.72–0.98; p = 0.024) and greater albuminuria severity were independently associated with risk. Compared with normal albuminuria, microalbuminuria and macroalbuminuria were associated with approximately fourfold and eightfold higher hazards, respectively (HR 4.15, 95% CI 1.91–9.00; and HR 7.73, 95% CI 4.01–14.90; both p < 0.001). For MACE, older age (HR per 10 years 1.52, 95% CI 1.12–2.06; p = 0.007) and diabetes mellitus (HR 3.00, 95% CI 1.60–5.62; p < 0.001) were independently associated with higher risk, while higher baseline eGFR was associated with lower risk in the treatment-adjusted models (HR per 10 mL/min/1.73 m2 0.76; p = 0.032–0.037). Neither time-dependent SGLT2 inhibitor nor ACE inhibitor/ARB use was significantly associated with MAKE or MACE. Fine–Gray competing-risk analyses yielded broadly consistent results. SGLT2 inhibitor exposure occurred in 75 patients (28.5%), and treatment-related findings should be interpreted cautiously given the limited exposure and observational design. Conclusions: MAKE and MACE were common in predialysis CKD. Lower baseline kidney function and albuminuria severity were associated with adverse kidney outcomes, whereas older age, diabetes mellitus, and lower baseline kidney function were associated with incident cardiovascular events. These findings highlight distinct renal and cardiovascular risk profiles in predialysis CKD.